QR Code

Synthesis and Evaluation of [<sup>18</sup>F]FEtLos and [<sup>18</sup>F]AMBF<sub>3</sub>Los as Novel <sup>18</sup>F-Labelled Losartan Derivatives for Molecular Imaging of Angiotensin II Type 1 Receptors

Losartan is widely used in clinics to treat cardiovascular related diseases by selectively blocking the angiotensin II type 1 receptors (AT<sub>1</sub>Rs), which regulate the renin-angiotensin system (RAS). Therefore, monitoring the physiological and pathological biodistribution of AT<sub>1</sub>R u...

Whakaahuatanga katoa

I tiakina i:
Ngā kaituhi matua: Martha Sahylí Ortega Pijeira, Paulo Sérgio Gonçalves Nunes, Sofia Nascimento dos Santos, Zhengxing Zhang, Arian Pérez Nario, Efrain Araujo Perini, Walter Miguel Turato, Zalua Rodríguez Riera, Roger Chammas, Philip H. Elsinga, Kuo-Shyan Lin, Ivone Carvalho, Emerson Soares Bernardes
Hōputu: Artigo
Reo:Inglês
I whakaputaina: MDPI AG 2020-04-01
Rangatū:Molecules
Ngā marau:
fluoroethyl-losartan
[<sup>18</sup>F]FEtLos
ammoniomethyltrifluoroborate-losartan
[<sup>18</sup>F]AMBF<sub>3</sub>Los
angiotensin II type 1 receptors
[<sup>18</sup>F]Fluoroethylation
Urunga tuihono:https://www.mdpi.com/1420-3049/25/8/1872
Ngā Tūtohu: Tāpirihia he Tūtohu
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!

Ngā tūemi rite